Table 1.
Congenital PRCA |
Diamond-Blackfan anemia |
Acquired PRCA |
Primary |
Primary autoimmune PRCA (includes transient erythroblastopenia of childhood) |
Primary myelodysplastic PRCA |
Secondary, associated with: |
Autoimmune/collagen vascular disorders |
Systemic lupus erythematosus |
Rheumatoid arthritis |
Inflammatory bowel disease |
Other immunologic mechanisms |
ABO-incompatible stem cell transplantation |
Pyoderma gangrenosum |
Lymphoproliferative disorders |
Chronic lymphocytic leukemia |
LGL leukemia |
Hodgkin disease |
Non-Hodgkin lymphomas |
Angioimmunoblastic lymphadenopathy |
Multiple myeloma |
Waldenstrom macroglobulinemia |
Castleman disease |
Other hematologic malignancies |
Chronic myelogenous leukemia |
Chronic myelomonocytic leukemia |
Myelofibrosis with myeloid metaplasia |
Essential thrombocythemia |
Acute lymphocytic leukemia |
Solid tumors |
Thymoma |
Gastric cancer |
Breast cancer |
Biliary cancer |
Lung cancer |
Thyroid cancer |
Renal cell carcinoma |
Carcinoma of unknown primary site |
Infections |
B19 parvovirus |
Human immunodeficiency virus |
T-cell leukemia-lymphoma virus |
Infectious mononucleosis |
Viral hepatitis (hepatitis A, B, C, and E) |
Cytomegalovirus |
Bacterial infections |
Group C Streptococcus |
Tuberculosis |
Bacterial sepsis |
Drugs and toxins |
rhEpo-induced Epo antibody-associated PRCA |
Other drugs (Table 2) |
Other disorders |
Pregnancy |
Riboflavin deficiency |
Modified from Lipton et al.44